Top Myocardial Infarction Companies in 2025
08 Jul, 2025

The global myocardial infarction market is anticipated to reach approximately US$ 3.64 billion by 2033, growing from US$ 2.14 billion in 2024 with a projected compound annual growth rate (CAGR) of 6.08% from 2025 to 2033. The market for myocardial infarction (MI) is fueled by sedentary lifestyles, aging populations, and the growing incidence of cardiovascular illnesses worldwide. Patient outcomes are being greatly enhanced by developments in interventional cardiology, diagnostic technologies, and pharmaceutical treatments such thrombolytics, beta-blockers, and antiplatelet medicines. The market is dominated by North America because of its high healthcare spending and awareness, but Asia-Pacific is predicted to rise quickly due to urbanization and better healthcare infrastructure. Abbott, AstraZeneca, and Novartis are important participants. Additionally, advancements in AI-based diagnostics and telemedicine are influencing the industry. Even with advancements, problems like exorbitant medical expenses and unequal access still exist. The market for MI is anticipated to expand gradually overall because to rising need for efficient preventative and treatment methods.

Discover key trends, growth opportunities, and major challenges shaping the Myocardial Infarction Industry in Renub Research’s latest in-depth market report. Download your free sample now

List of Leading Companies in the Myocardial Infarction Market

  1. Pfizer

Establishment: 1849

Headquarters: United States of America

Website: www.pfizer.com

Revenue: $63.6B in 2023

Pfizer Inc. is a biopharmaceutical firm that focuses on research. It finds, creates, produces, sells, and distributes medications and vaccines. Anti-infectives, cancer, cardiology, diabetes, obesity, inflammation, immunology, uncommon disorders, and bacterial infections are just a few of the therapeutic areas that the company's medicines address. Healthcare professionals, hospitals, clinics, and pharmacies utilize Pfizer's medicines to treat a range of illnesses. With names including Zavzpret, Abrysvo, Inflectra, Genotropin, Octagam, and Bosulif, among others, the corporation sells its goods through a network of wholesalers, merchants, and government organizations. Among other countries, it runs production facilities in Belgium, Germany, India, Ireland, Italy, Japan, Singapore, and the United States. The US city of New York is home to Pfizer's headquarters.

      2. Bristol-Myers Squibb

Establishment: 1887

Headquarters: United States of America

Website: www.bms.com

Revenue: $48.3B in 2023

The biopharmaceutical business Bristol-Myers Squibb Co. (BMS) is involved in the research, development, licensing, production, marketing, distribution, and retailing of novel biopharmaceutical drugs. The business sells its goods in therapeutic fields including neurology, immunology, cardiovascular disease, hematology, and cancer. In order to create certain medications, it also works with third parties through co-development, co-commercialization, licensing, or joint venture agreements. With brands including Opdivo, Reblozyl, Krazati, Sprycel, and Sotyktu, among others, BMS supplies wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government organizations. It has production facilities in the Netherlands, Puerto Rico, Ireland, Switzerland, and the United States. The US city of Princeton, New Jersey, is home to BMS's headquarters.

     3. AstraZeneca

Establishment: 1999

Headquarters: United Kingdom

Website: www.astrazeneca.com

Revenue: $54.1B in 2023

The biopharmaceutical business AstraZeneca Plc (AstraZeneca) is dedicated to the study, creation, and marketing of prescription drugs. Treatment development in the fields of oncology, cardiovascular, renal, and metabolic, respiratory, and immunology, as well as vaccines and immune therapies, and uncommon diseases, are among the company's primary endeavors. Vaccines, prescription drugs, and biologics are among the products offered by the company. AstraZeneca sells its medications to primary care and specialty care physicians through distributors, local representative offices, and fully owned local marketing organizations. The business has operations across Asia, Africa, Australasia, Europe, and the Americas. In order to improve product creation and the distribution process, it also works with governments, academic institutions, and other businesses. The UK's Cambridge, Cambridgeshire, is home to AstraZeneca's headquarters.

      4.Merck

Establishment: 1891

Headquarters: United States of America

Website: www.merck.com

Revenue: $64.2B in 2023

The biopharmaceutical business Merck & Co. Inc. (Merck) is responsible for the discovery, development, production, and marketing of medications, vaccines, biologic therapies, and animal health products. Prescription medications are available from the corporation within the following therapy areas: immunology, neurology, infectious illnesses, cardio-metabolic disorders, oncology, and ophthalmology. Additionally, it provides a large selection of veterinary medications, immunizations, health management services and solutions, and products for tracking, identification, and traceability. Pharmacies, hospitals, government agencies, health maintenance organizations, pharmacy benefit managers, veterinarians, distributors, animal producers, farmers, and pet owners are among the groups that use Merck's products. It runs production plants in Africa, Asia, Western Europe, South America, and North America. The US city of Rahway, New Jersey, is home to Merck's headquarters.

   5. Daiichi Sankyo

Establishment: 2005

Headquarters: Japan

Website: www.daiichisankyo.co.jp

Revenue: $13.1B in 2023

Global healthcare provider Daiichi Sankyo Co Ltd (Daiichi Sankyo) is dedicated to finding, creating, and providing cutting-edge medical solutions. The firm sells a variety of medications, including vaccinations, over-the-counter (OTC) medications, and prescription medications. Its product line includes medications for a variety of malignancies as well as neurological, nephrological, diabetic, metabolic, infectious, and cardiovascular disorders. The business also conducts research on immunological disorders and uncommon diseases in addition to cancer. Daiichi Sankyo uses a wide network of medical representatives in addition to its group firms to promote its goods. It operates in Europe, Asia, South and Central America, and North America. Tokyo, Japan, is home to Daiichi Sankyo's headquarters.

   6. Eli Lilly and Company

Establishment: 1876

Headquarters: United States of America

Website: www.lilly.com

Revenue: $45.0B in 2023

A pharmaceutical firm called Eli Lilly and Co. (Lilly) finds, creates, produces, and sells medical supplies for people. Its main products target therapeutic domains like neurology, immunology, cancer, and cardiometabolic health. Under the brands Basaglar, Humalog, Jardiance, Trulicity, Cyramza, and Emgality, the company distributes its pharmaceutical health products to wholesalers, pharmacy benefit managers, managed care organizations, group purchasing organizations, hospitals, government and long-term care facilities, and some retail pharmacies through independent wholesale distributors. North America, South America, Europe, the Middle East, Africa, and Asia-Pacific are all home to the company's production, distribution, and research and development centers. The US city of Indianapolis, Indiana, is home to Lilly's headquarters.

   7. Takeda

Establishment: 1781

Headquarters: Japan

Website: www.takeda.com

Revenue: $31.7B in 2024

Research, development, manufacturing, and marketing of biopharmaceutical drugs are the main activities of Takeda Pharmaceutical Co Ltd (Takeda), a pharmaceutical firm. In addition to treating major depressive disorder, attention-deficit hyperactivity disorder, hemophilia and hereditary bleeding disorders, primary immunodeficiency, multifocal motor neuropathy, inflammatory bowel disease, acid-related diseases, motility disorders, and liver diseases, it also treats cancer, including multiple myeloma, mantle cell lymphoma, non-small cell lung cancer, and chronic myeloid leukemia. The business works with marketing alliance partners globally in addition to directly promoting its pharmaceutical products. Japan, the US, Europe, Latin America, Africa, the Middle East, and the Asia-Pacific area are just a few of the nations where Takeda has operations. Japan's Tokyo is home to Takeda's headquarters.

    8. Novartis

Establishment: 1996

Headquarters: Switzerland

Website: www.novartis.com

Revenue: $51.7B in 2023

The pharmaceutical business Novartis AG (Novartis) is involved in the development, production, marketing, distribution, and distribution of novel medications. In therapeutic domains like cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology, it provides a variety of products. Through brands like Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, the company distributes its products to pharmacies, private health systems, government agencies, doctors, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems worldwide. It runs production plants in China, France, Italy, Switzerland, Austria, Slovenia, and the United States. The headquarters of Novartis are located in Basel, Switzerland.

   9. Bayer

Establishment: 1863

Headquarters: Germany

Website: www.bayer.com

Revenue: $50.4B in 2023

Bayer AG (Bayer) carries out the discovery, development, manufacturing, and commercialization of products for human health, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology, and other indications. It also strives to develop new molecules and technologies for use in the fields of medicine and modern agriculture. The company's product portfolio includes prescription products, specialty pharmaceuticals, diagnostic imaging equipment, non-prescription (over-the-counter or OTC) products, seeds, crop protection solutions and non-agricultural pest control solutions. Bayer markets its products through wholesalers, pharmacies, hospitals, and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East. Bayer is headquartered in Leverkusen, North Rhine-Westphalia, Germany.